Financials

  • Market Capitalization 4.01 M
  • Employee 52
  • Founded 1999
  • CEO Ofer Haviv
  • Website www.evogene.com
  • Headquarter Israel
  • FIGI UNKNOWN
  • Industry Biotechnology
Total revenue
Net income
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
5017
CANF
Can-Fite Biopharma Ltd American Depositary Shares, each represe
3.24 USD-2.11%-13.83%+8.36%-25.60%4.24 M USD
5020
ENSC
Ensysce Biosciences, Inc. - Common Stock
0.28 USD+3.70%-3.45%+7.69%-26.80%4.11 M USD
5026
REVB
Revelation Biosciences, Inc. - Common Stock
0.99 USD-1.00%-2.94%-2.94%-28.26%3.87 M USD
5028
SXTP
60 Degrees Pharmaceuticals, Inc. - Common Stock
1.45 USD-7.05%-17.14%+1.40%-30.29%3.86 M USD

Frequently asked questions about Evogene Ltd. - Ordinary Shares

What is the Evogene Ltd. - Ordinary Shares stock price today?

The current price of Evogene Ltd. - Ordinary Shares (EVGN) is 0.46. Over the past 24 hours, the stock has changed by -9.80%. Follow the EVGN chart for real-time price dynamics.

What is the stock ticker of Evogene Ltd. - Ordinary Shares?

Evogene Ltd. - Ordinary Shares trades under the ticker EVGN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Evogene Ltd. - Ordinary Shares stock going up?

EVGN has changed by +6.98% over the last week, -19.30% over the last month, and -64.06% over the last year. Review the chart to see whether the current move is part of a broader trend.

How many employees does Evogene Ltd. - Ordinary Shares have?

As of the latest available data, Evogene Ltd. - Ordinary Shares has 52 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Evogene Ltd. - Ordinary Shares stock?

You can buy Evogene Ltd. - Ordinary Shares (EVGN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Evogene Ltd. - Ordinary Shares stock?

Investing in Evogene Ltd. - Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the EVGN chart and related analysis on metatrader.com as part of your research.

Evogene Ltd. - Ordinary Shares

Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs. In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture.

News